Physician profile
John H Fahey
NPI 1144287020
$577.98
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $240 · 2020: $124 · 2021: $197 · 2022: $16.34.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $138.54 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $69.39 | 2020-2021 | |
| Novo Nordisk INC | $63.39 | 2019-2021 | |
| Amgen INC. | $52.95 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $45.89 | 2019-2021 | |
| Amarin Pharma, INC. | $32.03 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $30.65 | 2019-2021 | |
| Esperion Therapeutics, INC. | $29.82 | 2021 | |
| Lilly USA, LLC | $25.06 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $16.34 | 2022 | |
| Genentech USA, INC. | $14.01 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.36 | 2020 | |
| Circassia INC. | $12.19 | 2019 | |
| Janssen Pharmaceuticals, INC | $11.72 | 2021 | |
| Eisai INC. | $11.67 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $10.97 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Fahey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.